Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study

被引：0
作者：
Sachiko Ozawa
Daniel R. Evans
Colleen R. Higgins
Sarah K. Laing
Phyllis Awor
机构：
[1] University of North Carolina,Division of Practice Advancement and Clinical Education, UNC Eshelman School of Pharmacy
[2] University of North Carolina,Department of Maternal and Child Health, UNC Gillings School of Global Public Health
[3] Duke University School of Medicine,Department of Community Health and Behavioural Sciences
[4] Makarere University School of Public Health,undefined
来源：
Malaria Journal | / 18卷
关键词：
Antimalarial; Quality; Substandard; Falsified; Agent-based model; Uganda;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 221 条
[1]  
Maitland K(2016)Severe malaria in African children—the need for continuing investment N Engl J Med 375 2416-2417
[2]  
Gallup JL(2001)The economic burden of malaria Am J Trop Med Hyg 64 85-96
[3]  
Sachs JD(2008)Malaria and poverty Ann NY Acad Sci 1136 32-37
[4]  
Teklehaimanot A(2015)Falsified antimalarials: a minireview Expert Rev Ant Infect Ther 13 505-509
[5]  
Mejia P(2012)Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa Lancet Infect Dis 12 488-496
[6]  
Chaccour C(2006)Manslaughter by fake artesunate in Asia—will Africa be next? PLoS Med 3 e197-A2
[7]  
Kaur H(2011)Poor quality vital anti-malarials in Africa-an urgent neglected public health priority Malar J 10 352-440
[8]  
Pozo JLd(2018)Prevalence and estimated economic burden of substandard and falsified medicines in low- and middle-income countries: A systematic review and meta-analysis JAMA Net Open. 1 e181662-101
[9]  
Nayyar GM(2012)A systematic review of counterfeit and substandard medicines Arch Dis Childhood 97 A1-126
[10]  
Breman JG(2007)Antimalarial drug quality in Africa J Clin Pharm Ther 32 429-131
12345678910